Skip to content

EBITDA at other companies

Haemonetics logo
HaemoneticsHAE
$94.78M+7.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$74.65M+6.2%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

$41.5Mebit+
$12.9MDepreciation Depletion & Amortization
=$54.33M

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's EBITDA?
LivaNova (LIVN) reported EBITDA of $54.33M in Q1 2026.
How has LivaNova's EBITDA changed year-over-year?
LivaNova's EBITDA decreased by 8.3% year-over-year, from $59.25M to $54.33M.
What is the long-term trend for LivaNova's EBITDA?
Over 4 years (2021 to 2025), LivaNova's EBITDA has grown at a 75.8% compound annual growth rate (CAGR), from $25.73M to $245.65M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.